Renesas Electronics Reports Financial Results for the Third Quarter Ended December 31, 2012

TOKYO--(BUSINESS WIRE)--Renesas Electronics Corporation (TSE:6723) today announced consolidated financial results for the three months and nine months ended December 31, 2012.

Summary of Consolidated Financial Results

	Three months ended December 31, 2012		Nine months ended December 31, 2012
	Billion Yen	% of Net Sales	Billion Yen	% of Net Sales
Net sales	191.0	100.0	600.4	100.0
Sales from semiconductors	177.2		550.7
Sales from others	13.8		49.7
Operating income (loss)	(7.9)	(4.2)	(31.2)	(5.2)
Ordinary income (loss)	(11.1)	(5.8)	(35.5)	(5.9)
Net income (loss)	(46.6)	(24.4)	(161.7)	(26.9)
Capital expenditures	2.8		10.7
Depreciation and others	26.2		78.9
R&D expenses	32.8		109.0
	Yen		Yen
Exchange rate (USD)	79		80
Exchange rate (Euro)	102		102
	As of December 31, 2012
	Billion Yen
Total assets	716.7
Net assets	73.4
Equity Capital	63.3
Equity ratio (%)	8.8
Interest-bearing debt	316.2

Note 1:	All figures are rounded to the nearest 100 million yen.
Note 2:	Consolidated financial results for the nine months ended December 31, 2012 have not been reviewed by the auditors. The figures are subject to change based on subsequent events or the auditors’ review. Renesas Electronics Corporation will promptly notify the correction by issuing a press release.
Note 3:	Capital expenditures refer to the amount of order placed for property, plant and equipment (manufacturing equipment).
Note 4:	Depreciation and others includes depreciation and amortization of intangible assets and amortization of long-term prepaid expenses in quarterly consolidated statements of cash flows.

Consolidated Financial Results for the Third Quarter Ended December 31, 2012
English translation from the original Japanese-language document
	February 8, 2013
Company name	: Renesas Electronics Corporation
Stock exchanges on which the shares are listed	: Tokyo Stock Exchange, First Section
Code number	: 6723
URL	: http://www.renesas.com
Representative	: Yasushi Akao, President
Contact person	: Taizo Endo, Executive Manager
	Corporate Communications Dept
	Tel. [phone]
Filing date of Shihanki Hokokusho (scheduled)	: February 13, 2013
	(Amounts are rounded to the nearest million yen)

1. Consolidated financial results for the nine months ended December 31, 2012

1.1 Consolidated operating results (% of change from corresponding period of the previous year)

	Net sales		Operating income (loss)		Ordinary income (loss)		Net income (loss)
	Million yen	%	Million yen	%	Million yen	%	Million yen	%
Nine months ended December 31, 2012	600,398	(10.8)	(31,240)	---	(35,535)	---	(161,722)	---
Nine months ended December 31, 2011	673,431	(21.9)	(33,170)	---	(36,949)	---	(44,420)	---

Reference:	Comprehensive income for the nine months ended December 31, 2012: (153,083) million yen
	Comprehensive income for the nine months ended December 31, 2011: (54,735) million yen

	Net income (loss) per share basic	Net income (loss) per share diluted
	Yen	Yen
Nine months ended December 31, 2012	(387.71)	---
Nine months ended December 31, 2011	(106.49)	---

1.2 Consolidated financial position

	Total assets	Net assets	Equity ratio
	Million yen	Million yen	%
December 31, 2012	716,681	73,384	8.8
March 31, 2012	858,204	226,500	25.4

Reference:	Equity as of December 31, 2012:	63,276 million yen
	Equity as of March 31, 2012:	217,958 million yen

Note: Equity is equal to “Net assets” excluding “Share subscription rights” and “Minority interests”.

2. Cash dividends

	Cash dividends per share
	At the end of first quarter	At the end of second quarter	At the end of third quarter	At the end of year	Total
	Yen	Yen	Yen	Yen	Yen
Year ended March 31, 2012	---	0.00	---	0.00	0.00
Year ending March 31, 2013	---	0.00	---
Year ending March 31, 2013 (forecast)				0.00	0.00

Note: Change in forecast of cash dividends since the most recently announced forecast: No

3. Forecast of consolidated results for the year ending March 31, 2013

(% of change from corresponding period of the previous year)
	Net sales		Operating income (loss)		Ordinary income (loss)		Net income (loss)		Net income (loss) per share
	Million yen	%	Million yen	%	Million yen	%	Million yen	%	Yen	%
Year ending March 31, 2013	770,000	(12.8)	(26,000)	--	(34,000)	--	(176,000)	--	(421.94)	--

Note:	Change in for ecast of consolidated financial results since the most recently announced forecast: Yes
	For details, please refer to page 6.

4. Others

4.1 Changes in significant subsidiaries for the nine months ended December 31, 2012

(Changes in specified subsidiaries resulting in changes in scope of consolidation): No

4.2 Adoption of special accounting policies for quarterly financial statements: Yes

(Note) For details, please refer to page 7.

4.3 Changes in Accounting Policies, Changes in Accounting Estimates and Corrections of Prior Period Errors

1. Changes in accounting policies with revision of accounting standard: No

2. Changes in accounting policies except for 4.3.1: No

3. Changes in accounting estimates: No

4. Corrections of prior period errors: No

4.4 Number of shares issued and outstanding (common stock)

1. Number of shares issued and outstanding (including treasury stock)

As of December 31, 2012: 417,124,490 shares

As of March 31, 2012: 417,124,490 shares

2. Number of treasury stock

As of December 31, 2012: 2,548 shares

As of March 31, 2012: 2,548 shares

3. Average number of shares issued and outstanding

For the nine months ended December 31, 2012: 417,121,942 shares

For the nine months ended December 31, 2011: 417,121,942 shares

(Note) Information regarding the implementation of quarterly review procedures

These quarterly financial results are not subject to quarterly review procedures based upon the Financial Instruments and Exchange Act. These are under the review procedures for the quarterly financial report at the time of issuance of this report.

Cautionary Statement

The statements with respect to the financial outlook of Renesas Electronics Corporation and its consolidated subsidiaries are forward-looking statements involving risks and uncertainties. We caution you in advance that actual results may differ materially from such forward-looking statements due to changes in several important factors.